Literature DB >> 21491124

Definition of performance metrics and methods for screening for sudden cardiac arrest risk at a tertiary care medical center.

Robert F Rea1, Douglas Beinborn, Tracy Webster, Nancy Acker, Tammy Kester, David L Hayes, Mark McConnell.   

Abstract

PURPOSE: The purpose of this study is to describe the results of manual and automatic electronic medical record-based screening of patients at risk of sudden cardiac arrest (SCA) based on measurements of left ventricular ejection fraction (LVEF).
METHODS: Counseling regarding SCA risk and implantable cardioverter defibrillator (ICD) therapy is underutilized in patients with reduced LVEF. We developed and implemented an electronic medical record (EMR)-based system for screening of such patients to improve care. In phase one, manual screening of electronic records and LVEF databases was initially performed by trained cardiac device nurses. In phase two, records were screened automatically by a customized program, and candidate patient records were sent to cardiac device nurses for final review and disposition.
RESULTS: In phase one, 2,531 patients with LVEF ≤35% were identified over 398 days. Manual EMR review showed that 1,918 patients (76%) received appropriate counseling regarding SCA risk, received ICDs, or had disqualifying comorbidities. In phase two, 1,081 patients with LVEF ≤35% were identified after automatic screening of 44,672 echocardiograms and EMR over 251 days. Of these, 513 patients (58%) received appropriate counseling regarding SCA risk, received ICDs, or had disqualifying comorbidities.
CONCLUSIONS: These data detail the utilization of consultation regarding SCA risk and ICDs in patients with reduced LVEF at a tertiary care center with ready access to arrhythmia specialists. Notification of primary providers of reduced LVEF with recommendation for consultation was not effective in improving patient care.

Entities:  

Mesh:

Year:  2011        PMID: 21491124     DOI: 10.1007/s10840-011-9569-x

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN: 1383-875X            Impact factor:   1.900


  7 in total

Review 1.  Effectiveness and efficiency of guideline dissemination and implementation strategies.

Authors:  J M Grimshaw; R E Thomas; G MacLennan; C Fraser; C R Ramsay; L Vale; P Whitty; M P Eccles; L Matowe; L Shirran; M Wensing; R Dijkstra; C Donaldson
Journal:  Health Technol Assess       Date:  2004-02       Impact factor: 4.014

2.  Review of the registry's first year, data collected, and future plans.

Authors:  Stephen C Hammill; Lynne Warner Stevenson; Alan H Kadish; Mark S Kremers; Paul Heidenreich; Bruce D Lindsay; Michael J Mirro; Martha J Radford; Yongfei Wang; Christine M Lang; Joel C Harder; Ralph G Brindis
Journal:  Heart Rhythm       Date:  2007-07-25       Impact factor: 6.343

3.  ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons.

Authors:  Andrew E Epstein; John P DiMarco; Kenneth A Ellenbogen; N A Mark Estes; Roger A Freedman; Leonard S Gettes; A Marc Gillinov; Gabriel Gregoratos; Stephen C Hammill; David L Hayes; Mark A Hlatky; L Kristin Newby; Richard L Page; Mark H Schoenfeld; Michael J Silka; Lynne Warner Stevenson; Michael O Sweeney; Sidney C Smith; Alice K Jacobs; Cynthia D Adams; Jeffrey L Anderson; Christopher E Buller; Mark A Creager; Steven M Ettinger; David P Faxon; Jonathan L Halperin; Loren F Hiratzka; Sharon A Hunt; Harlan M Krumholz; Frederick G Kushner; Bruce W Lytle; Rick A Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel; Lynn G Tarkington; Clyde W Yancy
Journal:  J Am Coll Cardiol       Date:  2008-05-27       Impact factor: 24.094

4.  Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.

Authors:  Arthur J Moss; Wojciech Zareba; W Jackson Hall; Helmut Klein; David J Wilber; David S Cannom; James P Daubert; Steven L Higgins; Mary W Brown; Mark L Andrews
Journal:  N Engl J Med       Date:  2002-03-19       Impact factor: 91.245

5.  Hospital variation and characteristics of implantable cardioverter-defibrillator use in patients with heart failure: data from the GWTG-HF (Get With The Guidelines-Heart Failure) registry.

Authors:  Bimal Shah; Adrian F Hernandez; Li Liang; Sana M Al-Khatib; Clyde W Yancy; Gregg C Fonarow; Eric D Peterson
Journal:  J Am Coll Cardiol       Date:  2009-02-03       Impact factor: 24.094

6.  Sex and racial differences in the use of implantable cardioverter-defibrillators among patients hospitalized with heart failure.

Authors:  Adrian F Hernandez; Gregg C Fonarow; Li Liang; Sana M Al-Khatib; Lesley H Curtis; Kenneth A LaBresh; Clyde W Yancy; Nancy M Albert; Eric D Peterson
Journal:  JAMA       Date:  2007-10-03       Impact factor: 56.272

7.  Preventing tomorrow's sudden cardiac death today: dissemination of effective therapies for sudden cardiac death prevention.

Authors:  Sana M Al-Khatib; Gillian D Sanders; Mark Carlson; Aida Cicic; Anne Curtis; Gregg C Fonarow; Peter W Groeneveld; David Hayes; Paul Heidenreich; Daniel Mark; Eric Peterson; Eric N Prystowsky; Philip Sager; Marcel E Salive; Kevin Thomas; Clyde W Yancy; Wojciech Zareba; Douglas Zipes
Journal:  Am Heart J       Date:  2008-07-26       Impact factor: 4.749

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.